electroCore (NASDAQ:ECOR) Director Sells $544,000.00 in Stock

electroCore, Inc. (NASDAQ:ECOR) Director Daniel Goldberger sold 80,000 shares of electroCore stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $6.80, for a total value of $544,000.00. Following the transaction, the director directly owned 211,471 shares of the company’s stock, valued at $1,438,002.80. The trade was a 27.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

electroCore Price Performance

ECOR stock traded up $0.07 during mid-day trading on Friday, reaching $10.25. 153,518 shares of the company traded hands, compared to its average volume of 88,040. The company has a market capitalization of $85.08 million, a P/E ratio of -5.79 and a beta of 0.83. electroCore, Inc. has a 52-week low of $4.16 and a 52-week high of $10.45. The company has a fifty day moving average price of $7.24 and a 200-day moving average price of $6.37.

electroCore (NASDAQ:ECOR) last posted its earnings results on Wednesday, May 6th. The company reported ($0.59) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.59). The business had revenue of $9.58 million during the quarter, compared to analyst estimates of $9.01 million. electroCore had a negative return on equity of 1,956.38% and a negative net margin of 44.08%. As a group, analysts forecast that electroCore, Inc. will post -1.48 EPS for the current year.

Wall Street Analysts Forecast Growth

ECOR has been the subject of several research analyst reports. Zacks Research raised electroCore from a “strong sell” rating to a “hold” rating in a research note on Friday, March 27th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of electroCore in a report on Friday, March 27th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, electroCore has a consensus rating of “Hold” and a consensus price target of $18.00.

Hedge Funds Weigh In On electroCore

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Jaffetilchin Investment Partners LLC increased its holdings in shares of electroCore by 7.4% in the 4th quarter. Jaffetilchin Investment Partners LLC now owns 52,363 shares of the company’s stock worth $235,000 after buying an additional 3,600 shares during the last quarter. Two Sigma Investments LP lifted its holdings in shares of electroCore by 20.8% during the 3rd quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock worth $122,000 after acquiring an additional 4,231 shares during the last quarter. International Assets Investment Management LLC grew its position in electroCore by 15.2% in the fourth quarter. International Assets Investment Management LLC now owns 88,720 shares of the company’s stock worth $398,000 after acquiring an additional 11,700 shares in the last quarter. FNY Investment Advisers LLC purchased a new position in electroCore in the fourth quarter worth $82,000. Finally, Jane Street Group LLC increased its stake in electroCore by 114.4% in the first quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after acquiring an additional 19,599 shares during the last quarter. Hedge funds and other institutional investors own 26.74% of the company’s stock.

electroCore Company Profile

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.